Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate the diagnostic efficacy and differences between 18F-FDG PET/CT and MR STIR sequences combined with EBUS-TBNA, 18F-FDG PET/CT combined with EBUS-TBNA, and MR STIR sequences combined with EBUS-TBNA - three types of multimodal imaging for assessing NSCLC N-stage, in order to select the best assessment protocol to guide treatment decisions and prognostic assessments.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05840094
Study type Interventional
Source Peking University First Hospital
Contact Meng Liu
Phone +86 13261995618
Email louisa_liu@bjmu.edu.cn
Status Not yet recruiting
Phase N/A
Start date May 1, 2023
Completion date May 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT06079970 - Confocal Laser Endomicroscopy VERification N/A
Recruiting NCT04062045 - Efficacy of Continous Regional Anesthesia Using m. Erector Spinae Catheter After VATS Procedures N/A
Completed NCT03986463 - CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility
Recruiting NCT04566614 - Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies
Not yet recruiting NCT06354959 - Prehab for Lung and Esophageal Cancer N/A
Completed NCT04432753 - Effect of Incidental Findings Information on Lung Cancer Screening Intent N/A
Completed NCT03123783 - CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab Phase 1/Phase 2
Active, not recruiting NCT03678883 - 9-ING-41 in Patients With Advanced Cancers Phase 2
Completed NCT04665531 - Postoperative Analgesia With a Catheter Under the Erector Spinae Muscle for Videothoracoscopic Lung Surgery N/A
Completed NCT04314895 - Trial of NanoPac Intratumoral Injection in Lung Cancer Phase 2